Skip to main content
Clinical Trials/NCT02096523
NCT02096523
Completed
Not Applicable

Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder

Ela Shai1 site in 1 country4 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inherited Platelet Disorders
Sponsor
Ela Shai
Enrollment
4
Locations
1
Primary Endpoint
Levels of detectable platelet proteins
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The goal of this study is to identify the platelet defect responsible for the bleeding in families from our inherited platelet disorders Israeli-Palestinian registry. The investigators plan to characterize platelet proteome expression after removing high abundance proteins. The investigators will compare the proteome of sick and healthy members of families with inherited platelet disorders, and identify and validate structural proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet disorders. The investigators expect to discover new key findings that allow better understanding of human platelet function and allow better diagnosis and treatment of patients with inherited platelet function disorders.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
July 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ela Shai
Responsible Party
Sponsor Investigator
Principal Investigator

Ela Shai

Researcher at Hadassah Medical Center

Hadassah Medical Organization

Eligibility Criteria

Inclusion Criteria

  • History of inherited platelet disorders in the family

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Levels of detectable platelet proteins

Time Frame: 2014-2015 (1 year)

Characterize platelet proteome expression profile

Secondary Outcomes

  • Changes in protein expression from sick and healthy platelets(2015-2019 (4 years))

Study Sites (1)

Loading locations...

Similar Trials